ASPYRE-Lung addresses critical gaps in NGS-based biomarker testing: Late Breaking Abstract data demonstrate 98% of NGS QC fails can be rescued CAMBRIDGE, England and RESEARCH TRIANGLE PARK, N.C., April 5, 2024 /PRNewswire/ — Biofidelity, a revolutionary genomic technology company…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.